ORIGINAL RESEARCH article

Front. Microbiol.

Sec. Antimicrobials, Resistance and Chemotherapy

Volume 16 - 2025 | doi: 10.3389/fmicb.2025.1580739

This article is part of the Research TopicMultidrug Resistant Gram-negative Bacteria in Fragile HostsView all 5 articles

Dissemination of KPC-2-Producing Carbapenem-Resistant Klebsiella pneumoniae ST792 in Southern China

Provisionally accepted
Cailing  WanCailing Wan1,2Meilan  LiMeilan Li1Haojin  GaoHaojin Gao1Peiyao  ZhouPeiyao Zhou1,3Bingjie  WangBingjie Wang1JunHong  ShiJunHong Shi1Li  ShenLi Shen1Weihua  HanWeihua Han1Xinru  YuanXinru Yuan1Jianbo  lvJianbo lv1,2Yu  HuangYu Huang1,3Ying  ZhouYing Zhou1*Fangyou  YuFangyou Yu1*
  • 1Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China
  • 2School of Public Health, Nanchang University, Nanchang, Jiangxi Province, China
  • 3Department of Laboratory Medicine, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China

The final, formatted version of the article will be published soon.

The global emergence of carbapenem-resistant Klebsiella pneumoniae (CRKP) has become a critical public health threat. However, the epidemiological significance of certain sequence types (STs) remains underappreciated. Among these, ST792-a lineage rarely documented in global surveillance studies-has recently emerged as a concerning threat in southern China. In this study, we characterized the epidemiological features and antimicrobial resistance mechanisms of CRKP ST792 isolates collected during a dissemination in a hospital in southern China.Seven separate clinical isolates were collected from hospitalized patients between January 2021 and March 2022. Bacterial isolates were identified, and antimicrobial susceptibility testing was conducted using the VITEK-2 compact automated system. Whole-genome sequencing 2 (WGS) was performed on all seven isolates to confirm the presence of resistance genes.Additionally, a representative strain (G5) was selected for in-depth genomic characterization using long-read sequencing to analyze its genetic features and mobile genetic elements. Conjugation experiments were conducted to assess the transferability of the resistance plasmids.All isolated strains were identified as ST792-type CRKP carrying blaKPC-2 through whole-genome sequencing. The strains harbored additional resistance genes including blaSHV-148, blaCTX-M-3, blaTEM-1B, qnrS1, OqxA and OqxB. Genomic characterization of representative strain G5 revealed a circular chromosome and three resistance plasmids. The blaKPC-2 gene was located on a 102,257 bp IncFIB(pQil) plasmid with a Tn3-TnpR-ISKpn27-ISKpn28-blaKPC-2-ISKpn6 genetic structure. Conjugation experiments demonstrated successful transfer of two accessory plasmids (p[G5]-2 and p[G5]-3) to Escherichia coli EC600, confirming their mobility and potential role in resistance gene dissemination.This study characterizes the nosocomial dissemination of KPC-2-producing K. pneumoniae ST792 strains, elucidating their antimicrobial resistance patterns and plasmid-mediated transmission mechanisms to inform infection control strategies. The urgent need for enhanced surveillance and strict implementation of infection control measures is underscored to mitigate the spread of hospital-acquired multidrug-resistant pathogens.

Keywords: carbapenem-resistant Klebsiella pneumoniae, Molecular Epidemiology, dissemination, ST792, Whole-genome sequencing

Received: 21 Feb 2025; Accepted: 19 May 2025.

Copyright: © 2025 Wan, Li, Gao, Zhou, Wang, Shi, Shen, Han, Yuan, lv, Huang, Zhou and Yu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Ying Zhou, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China
Fangyou Yu, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.